Posts

Showing posts with the label Growth rate report to 2017

Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline Review, H1 Market size, Growth rate report to 2017

Radiant insights, inc latest Pharmaceutical and Healthcare disease pipeline guide Attention Deficit Hyperactivity Disorder - Pipeline Review, H1 2017, provides an overview of the Attention Deficit Hyperactivity Disorder (Central Nervous System) pipeline landscape. Attention deficit hyperactivity disorder (ADHD) is a group of behavioral symptoms that include inattentiveness, hyperactivity and impulsiveness. Symptoms of ADHD include disorganized work habits, procrastination and inability to sustain attention on tasks or activities. Treatment includes analeptics. Report Highlights Radiant insights, inc Pharmaceutical and Healthcare latest pipeline guide Attention Deficit Hyperactivity Disorder - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Attention Deficit Hyperactivity Disorder (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and...